Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Lupus Science & Medicine|April 22, 2016
The history of pulse therapy in lupus nephritis (1976-2016)Morton ScheinbergRevista Brasileira De Reumatologia|January 19, 2011
Infliximab use and sequential occurrence of autoantibodies and neoplasia in a patient with spondyloarthritisRicardo Golmia, Morton ScheinbergAutoimmunity Reviews|December 21, 2018
The future landscape of biosimilars in rheumatology: Where we are where we are goingMorton Scheinberg, Valderilio AzevedoJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|April 7, 2007
Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemiaEduardo Finger, Morton ScheinbergSeminars in Arthritis and Rheumatism|July 21, 2007
The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a reviewBeni Grinblat, Morton ScheinbergAutoimmunity Reviews|November 29, 2017
Belimumab in the treatment of systemic lupus erythematous: An evidence based review of its place in therapyFrederico Marcondes, Morton ScheinbergSpringerplus|May 2, 2015
Real life experience on the effect of Belimumab in patients with active systemic lupusMorton Scheinberg, Ricardo GolmiaArthritis Research & Therapy|February 14, 2015
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practiceMorton Scheinberg, Gilberto Castañeda-HernándezClinical Rheumatology|December 19, 2007
Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative associationLuiz Sergio Guedes-Barbosa, Cristovão Mangueira, Morton ScheinbergRevista Brasileira De Reumatologia|July 24, 2014
When anti-TNF fails, anti-IL12-23 is an alternate option in psoriasis and psoriatic arthritisRicardo Prado Golmia, Ayk Helena Barbosa Martins, Morton ScheinbergPageof 4